Chemical and Biological Defense Program

Our initial expectations were that we would interview far more FDA officials than we did. However, we ended up interviewing more DoD officials, at all levels of policy and operations. Officials were interviewed in the following DoD offices Anthrax Vaccine Immunization Program (AVIP) J-4 Eogistics Directorate Office of the ASD(HA) JPO-BD the Defense Supply Center in Philadelphia Office of the Assistant to the Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs U.S. Army Soldier Biological and Chemical Command U.S. Army Medical Materiel Development Activity and U.S. Army Medical Research Institute of Infectious Diseases... 

U.S. Department of Defense, Chemical and Biological Defense Program, Annual Report to Congress and Performance Plan, July 2001b. 

The Navy, and with it the Joint Chemical and Biological Defense Program, should shift from a philosophy dominated by contamination avoidance toward an approach based on risk management which assumes that contamination will happen and focuses on managing the response. The foundation for a risk management approach should come from the doctrine development efforts at the Navy Warfare Development Command (as recommended in Chapter 3 of this report) and from the results of the operational net assessments in each area of responsibility (as recommended in Chapter 3). 

U.S. Department of Defense (DoD), 2000. Chemical and Biological Defense Program, Annual report to Congress, March 2000. available at http //www.acq.osd.mil/cp/cbdreports/ nbc00.pdf (accessed September 15, 2007). 

Title XIV of the Defense Authorization Act of 1997 (PL 104-201), championed by Senators Nunn, Lugar, and Domenici, directed the Defense Department to assist federal, state, and local officials with training, technical advice, equipment, and other actions necessary to increase the local response capabilities to respond to and manage the consequences of a WMD terrorist incident. Specifically, the Defense Department was directed to assist civilian officials in developing chemical and biological defensive programs, and to help the Public Health Service to organize Metropolitan Medical Strike Teams. 

DoD Chemical and Biological Defense Program (CBDP) Transformational Medical technologies Initiative 2008 Report to Congress, http //www.tmti-cbdefense.org/. 

The National Research Council (NRC) of the National Academy of Sciences (NAS) will identity the scientific and technology capabilities that must be available to support Chemical and Biological Defense Program (CBDP) research, development, test and evaluation, and operational activities, and provide guidance on which of these capabilities can be obtained outside the Military Service laboratories, which are unavailable except in the Military Service laboratories, and which are so mission-critical (classified, nonproliferation, or other) that they should be maintained in the Military Ser dce laboratories. It will review relevant Department of Defense (DoD) studies and other pertinent literature, and conduct site visits and interviews with all necessary CBDP and DoD Laboratory stakeholders to collect the data to accomplish the study objectives. It will provide guidance for coordination and... 

The committee was advised that this report is intended to be used in developing the POM (Program Objective Memorandum) for the Chemical and Biological Defense Program. 

In identifying the science and technology capabilities necessary to support the Chemical and Biological Defense program, the committee identified the following principle findings and recommendations. 

---